Clinical Trials Logo

Percutaneous Nephrolithotomy clinical trials

View clinical trials related to Percutaneous Nephrolithotomy.

Filter by:

NCT ID: NCT06393062 Recruiting - Clinical trials for Percutaneous Nephrolithotomy

Gram Stain of the First Urine After Puncture in Percutaneous Nephrolithotomy

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

In this study, investigators compared the systemic inflammatory responses after percutaneous nephrolithotomy (PCNL) patients who were given an expanded empirical antibiotic regimen based on the prediction of the possibility of bacteria identified by Gram staining the first urine after renal puncture and patients whose antibiotic regimen was not performed and whose antibiotic regimen was adjusted according to patient symptoms and culture results. Investigators aimed to test its diagnostic value in predicting and preventing complications.

NCT ID: NCT06266793 Not yet recruiting - Nephrolithiasis Clinical Trials

Comparison of Holmium Laser and Thulium Laser for Mini PCNL

HOTLaser
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

This is a single institution, single surgeon, randomized controlled trial to evaluate the Boston Scientific Lumenis Pulse 120H Moses 2.0 holmium laser versus the Olympus Soltive Superpulsed thulium fiber laser (TFL) for medium-to-large stones in the mini PCNL setting.

NCT ID: NCT06141746 Not yet recruiting - Clinical trials for Percutaneous Nephrolithotomy

Ultrasound Assessment of Extravascular Lung Water in Patients Undergoing Percutaneous Nephrolithotomy

Start date: April 2024
Phase:
Study type: Observational

Early detection of fluid accumulation in alveolar, interstitial and intracellular compartments of the lung due to intravascular absorption of irrigation fluid of PNL guided by lung ultrasound by detection of sonographic B lines.

NCT ID: NCT05947435 Completed - Clinical trials for Percutaneous Nephrolithotomy

Tranexamic Acid in Percutaneous Nephrolithotomy

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Tranexamic acid, once a randomly used antifibrinolytic agent, has been in standard protocols for many specific surgeries. Studies are still needed to standardize the dose and route of tranexamic acid administration, examine its possible contributions in urological surgery, and establish a protocol for its use. To contribute to this goal, the study was designed as a prospective, randomized, double-blind study on 75 patients with one control and 2 study groups (n=25) who underwent percutaneous nephrolithotomy. Group Tranexamic acid received 10 mg/kg intravenous tranexamic acid preoperatively. And Group Irrigation received the same amount in the initial irrigation fluid. Primarily,the total amount of blood transfusion and the changes in haemoglobin and haematocrit values during two postoperative days were observed. Distinctively, continuous intraoperative haemoglobin saturation was monitored. Secondarily, surgical visual clarity with a standard visual score was questioned to reveal its contribution to surgical practicality, operative time, and residual fragment quantity.

NCT ID: NCT05855057 Completed - Clinical trials for Ultrasound Therapy; Complications

Effectiveness of US-Guided PCNL Different Positions in Renal Stones Treatment

Start date: January 20, 2018
Phase:
Study type: Observational

The aim of this study is to compare the effectiveness of Ultrasound-Guided Percutaneous nephrolithotomyin different positions supine, prone positions and flank suspend supine position in renal stones treatment.

NCT ID: NCT05725083 Not yet recruiting - Clinical trials for Percutaneous Nephrolithotomy

Lower Thoracic Epidural vs Erector Spinae Block for PNL

Start date: January 11, 2024
Phase: N/A
Study type: Interventional

compare the efficacy of Lower Thoracic Epidural with Erector spinae plane block (ESPB) for post-operative analgesia after Percutaneous Nephrolithotomy with a hypothesis that both Lower Thoracic Epidural and Erector spinae plane block are effective in providing post-operative analgesia.

NCT ID: NCT05661175 Recruiting - Clinical trials for Percutaneous Nephrolithotomy

Application of One-handed Lithotripsy in Percutaneous Nephrolithotomy

Start date: December 3, 2022
Phase: N/A
Study type: Interventional

Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi.Traditional percutaneous nephrolithotomy usually requires the lithotripsy with the left hand holding the nephroscope and the right hand adjusting the laser fiber,which requires a lot of practice to master this technique.The goal of this study is to explore the safety and effectiveness of the PCNL with one-handed lithotripsy technique

NCT ID: NCT05574517 Recruiting - Urinary Calculi Clinical Trials

Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

Start date: October 7, 2022
Phase: N/A
Study type: Interventional

Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi. The advent of tubeless PCNL (without indwelling nephrostomy tube) has been proved to be safe and effective in reducing postoperative discomfort, shortening hospitalization time and reducing hospitalization costs. Traditional tubeless PCNL usually involves retrograde insertion of the ureteral catheter, which may cause many ureteral related surgical complications. However, there are few reports on tubeless PCNL without reverse ureteral catheter insertion. The goal of this study is to explore the safety and effectiveness of the tubeless PCNL without reverse ureteral catheter insertion.

NCT ID: NCT05467878 Completed - Clinical trials for Percutaneous Nephrolithotomy

The Effect of Anesthesia on Pain in Percutaneous Nephrolithotomy

Start date: March 1, 2021
Phase:
Study type: Observational

It is aimed to determine the ideal application by determining the effect of different anesthesia methods applied in percutaneous nephrolithotomy surgeries on analgesic consumption and pain level.

NCT ID: NCT05077007 Recruiting - Acute Kidney Injury Clinical Trials

Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures